Detection of Proarrhythmia in the Female Rabbit Heart:-Reference-Cited by-同舟云学术

Detection of Proarrhythmia in the Female Rabbit Heart:

Published:2003-03 Issue:3 Volume:14 Page:287-294
ISSN:1045-3873
Container-title:Journal of Cardiovascular Electrophysiology
language:en
Short-container-title:Journal of Cardiovascular Electrophysiology

Author:

HONDEGHEM LUC M.¹,LU HUA RONG²,ROSSEM KOEN van²,De CLERCK FRED²

Affiliation:

1. Department of Pharmacology, K.U. Leuven, Leuven, Belgium

2. Center of Excellence for Cardiovascular Safety Research, Johnson & Johnson Pharmaceutical Research & Development, a Division of Janssen Pharmaceutica, Beerse, Belgium

Publisher

Wiley

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1540-8167.2003.02466.x

Reference68 articles.

1. Anon: Points to consider:The assessment of the potential for QT interval prolongation by non‐cardiovascular medicinal products. Committee for Proprietary Medicinal Products (CPMP) Human Medicines Evaluation Unit London 1997 Publication No. CPMP 986/96.

2. The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

3. Development of Drugs That Alter Ventricular Repolarization

4. Instability and Triangulation of the Action Potential Predict Serious Proarrhythmia, but Action Potential Duration Prolongation Is Antiarrhythmic

5. Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-Induced QT Prolongation;Reference Module in Biomedical Sciences;2024

2. Cross clinical-experimental-computational qualification of in silico drug trials on human cardiac purkinje cells for proarrhythmia risk prediction;Frontiers in Toxicology;2022-10-05

3. Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs;EP Europace;2020-11-17

4. Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae;Frontiers in Physiology;2018-01-05

5. Role of abnormal repolarization in the mechanism of cardiac arrhythmia;Acta Physiologica;2017-07